| 영문 | medication | 한글 | 투약, 약물처치 |
|---|---|---|---|
| 설명 | 병이나 상처를 치료하기 위해 먹거나 바르거나 주사하는 것 |
||
| AC | abdominal circumference; abdominal compression; absorption coefficient; abuse case; acetate; acetylc... |
|---|---|
| ACD | absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom... |
| ACT | achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ... |
| CAC | cardiac-accelerator center; cardiac arrest code; circulating anticoagulant |
| LA | lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left... |
| MEMS | Medication Event Monitoring System |
|---|---|
| AC | Anticoagulant |
| LAC | Lupus AntiCoagulant |
| OAC | Oral anticoagulant |
| OAT | Oral anticoagulant therapy |
| medication, anti-coagulant | Blood thinners. Drugs, like heparin and warfarin, used as blood-thinners to prevent blood clots and to maintain open blood vessels. (12 Dec 1998) |
|---|
| anticoagulant | <haematology, pharmacology> Any substance that prevents blood clotting. Those drugs administered for prophylaxis or treatment of thromboembolic disorders are heparin, which inactivates thrombin and several other clotting factors and which must be administered parenterally and the oral anticoagulants (warfarin, dicumarol and congeners) which inhibit the hepatic synthesis of vitamin K dependent clotting factors. Anticoagulant solutions used for the preservation of stored whole blood and blood fractions are acid citrate dextrose (ACD), citrate phosphate dextrose (CPD), citrate phosphate dextrose adenine (cPDA 1) and heparin. Anticoagulants used to prevent clotting of blood specimens for laboratory analysis are heparin and several substances that make calcium ions unavailable to the clotting process, including EDTA (ethylenediaminetetraacetic acid), citrate, oxalate and fluoride. (18 Nov 1997) |
|---|---|
| anticoagulant therapy | The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting. (05 Mar 2000) |
| vascular anticoagulant | <protein> Group of calcium-binding proteins that interact with acidic membrane phospholipids in membranes. They contain 4 or 8 repeats of a 61 amino acid domain that folds into 5 a helices. Also known by several other names (e.g. Lipocortins, endonexins), reflecting the history of their discovery in different contexts. See: lipocortin, endonexin I & II, calpactin, p70 and calelectrin. (18 Nov 1997) |
| lupus anticoagulant | An immunoglobulin that interferes with blood coagulation and has antithromboplastin activity. This immunoglobulin can prolong blood clotting and occurs in approximately 25% of people with lupus. (27 Sep 1997) |
| arrhenic medication | Treatment of disease by means of the organic preparations of arsenic, the cacodylates, and methylarsinates. (05 Mar 2000) |
| maintenance medication | Medication taken to stabilise an illness or symptoms of illness. (05 Mar 2000) |
| medication | 1. Impregnation with a medicine. 2. <pharmacology> The administration of remedies. 3. A medicament. Origin: L. Medicatio (05 Jan 1998) |
| medication, ace-inhibitor | Agents that inhibit ACE (angiotensin-converting enzyme), thereby acting as vasodilators (really as anti-vasoconstrictors), lightening the stress load on the heart. (12 Dec 1998) |
| medication, anti-platelet | Platelet-blocking drugs. Drugs that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| medication, beta-blocker | Drugs that antagonise the action of adrenaline (a beta adrenergic substance) and relieve stress to the heart muscle. Beta-blockers are often used to slow the heart rate or lower the blood pressure. (12 Dec 1998) |
| medication, clot-dissolving | Drugs used to dissolve blood clots. Agents such as plasminogen-activator (t-pa) and streptokinase that are effective in dissolving clots and re-opening arteries. Used, for example, in the treatment of heart attacks. Clot-dissolvers are also called thrombolytic agents. (12 Dec 1998) |
| medication errors | Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the proper dose of the drug in the treatment of his disease. (12 Dec 1998) |
| medication systems | Overall systems, traditional or automated, to provide medication to patients. (12 Dec 1998) |
| medication systems, hospital | Overall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician's order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient. (12 Dec 1998) |
| medication, vasodilator | Drugs that act as blood vessel dilator (vasodilators) and open vessels by relaxing their muscular walls). For example, nitroglycerin is a vasodilator. So are the ace (angiotensin-converting enzyme) inhibitors. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|